- AuthorisedPhase III and phase IV (Integrated)
A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme
This study is looking at two different hormone medicines, Rekovelle and Menopur, used in fertility treatments like IVF. Researchers want to see which one helps women produce more good-quality eggs. It aims to improve chances of pregnancy for women needing fertility help.
For: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleItaly · Spain - AuthorisedTherapeutic confirmatory (Phase III)
Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.
This study looks at whether a testosterone gel, used before IVF, can help women who have fewer eggs and a specific genetic marker. The main goal is to see if it increases the number of eggs collected, potentially improving chances for those struggling to conceive.
For: low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphismSpain